Filtros de búsqueda

Lista de obras de Giuseppe Curigliano

"The only thing I know is that I know nothing": 5-fluorouracil in human milk

artículo científico publicado en 2012

'Tu quoque Brute fili mihi!' (Julius Caesar, Ides of March, 44 BC): role of tumor microenvironment and immune system in breast cancer progression

artículo científico publicado en 2014

3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).

artículo científico publicado en 2017

3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).

artículo científico publicado en 2017

3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3).

artículo científico publicado en 2016

4-Aminobiphenyl-DNA adducts in laryngeal tissue and smoking habits: an immunohistochemical study

artículo científico publicado en 1998

4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†

artículo científico publicado en 2018

A clinical perspective on escalating or de-escalating adjuvant therapy in HER2+ breast cancer

artículo científico publicado en 2018

A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer

artículo científico publicado en 2017

A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases

artículo científico publicado en 2013

A new approach to assess drug sensitivity in cells for novel drug discovery.

artículo científico publicado en 2018

A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors.

artículo científico publicado en 2016

A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer.

artículo científico publicado en 2016

A phase II trial of the CDK4/6 inhibitor palbociclib (P) as single agent or in combination with the same endocrine therapy (ET) received prior to disease progression, in patients (pts) with hormone receptor positive (HR+) HER2 negative (HER2−) meta

A proper schedule of weekly paclitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patients

artículo científico publicado en 2006

A randomized phase II trial comparing preoperative plus perioperative chemotherapy with preoperative chemotherapy in patients with locally advanced breast cancer.

artículo científico publicado en 2006

A randomized, double-blinded, controlled study of tucatinib (ONT-380) vs. placebo in combination with capecitabine (C) and trastuzumab (Tz) in patients with pretreated HER2+ unresectable locally advanced or metastatic breast carcinoma (mBC) (HER2CLIM

A role for the immune system in advanced laryngeal cancer

artículo científico publicado en 2020

A rude awakening from tumour cells

artículo científico publicado en 2018

Absence of epidermal growth factor receptor gene mutations in patients with hormone refractory prostate cancer not responding to gefitinib

article

Acute vulvar vestibulitis occurring during chemotherapy with cryptophycin analogue LYy355703

artículo científico publicado en 2000

Addition of platinum salts to neoadjuvant chemotherapy in triple-negative breast cancer: a new standard of care?

artículo científico publicado en 2018

Adjuvant therapy for very young women with breast cancer: response according to biologic and endocrine features.

artículo científico publicado en 2004

Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: a systematic review of randomized controlled trials.

artículo científico

Adjuvant treatment of early male breast cancer

scientific article published on 26 August 2020

Antiangiogenic therapy in recurrent breast cancer with lymphangitic spread to the chest wall: A randomized phase II trial of bevacizumab with sequential or concurrent oral vinorelbine and capecitabine.

artículo científico publicado en 2015

Antibody-drug conjugates in breast cancer: the chemotherapy of the future?

scientific article published on 09 July 2020

Are all cyclin-dependent kinases 4/6 inhibitors created equal?

scientific article published on 29 August 2019

Are all high-grade breast cancers with no steroid receptor hormone expression alike? The special case of the medullary phenotype

article

Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Ca

artículo científico publicado en 2017

Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in I

artículo científico publicado en 2017

Association between baseline tumour burden and outcome in patients with cancer treated with next-generation immunoncology agents

scientific article published on 23 September 2020

Autologous fat transplantation in patients with breast cancer: "silencing" or "fueling" cancer recurrence?

artículo científico publicado en 2011

Barriers to the Use of Trastuzumab for HER2+ Breast Cancer and the Potential Impact of Biosimilars: A Physician Survey in the United States and Emerging Markets

artículo científico publicado en 2014

Being more precise in assessing the value of precision medicine in breast cancer

artículo científico publicado en 2016

Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review

artículo científico

Best management of locally advanced inoperable breast cancer

artículo científico publicado en 2013

Biologic therapy for advanced breast cancer: recent advances and future directions

scientific article published on 07 April 2020

Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives

artículo científico publicado en 2014

Biopsy of liver metastasis for women with breast cancer: Impact on survival

article by Edoardo Botteri et al published June 2012 in The Breast

Biosimilars for breast cancer

artículo científico publicado en 2019

Biosimilars: Extrapolation for oncology

artículo científico publicado en 2016

Bone scan had no role in the staging of 765 consecutive operable T1–2N0–1 breast cancer patients without skeletal symptoms

artículo científico publicado en 2001

Breast and ovarian metastatic localization of signet-ring cell gastric carcinoma

artículo científico publicado en 2003

Breast cancer mortality in European Union: An outlook of good news and bad news in a two-speed Europe!

scientific article published on 19 July 2017

Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction.

artículo científico publicado en 2013

Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients.

artículo científico publicado en 2004

Breast conservation following neoadjuvant therapy for breast cancer in the modern era: Are we losing the opportunity?

artículo científico publicado en 2016

CDK4/6 inhibitors for HR+HER2- early stage breast cancer - when to escalate treatment?

artículo científico publicado en 2020

CDX-2 should be included in the work-up of patients with lung metastases from unknown primary

artículo científico publicado en 2004

CMF revisited in the 21st century ⬇️

artículo científico publicado el 29 de junio de 2011

Cancer-testis antigen expression in triple-negative breast cancer

artículo científico publicado en 2010

Cardiac toxicity from systemic cancer therapy: a comprehensive review.

artículo científico publicado en 2010

Cardio-Oncology Training: A Proposal From the International Cardioncology Society and Canadian Cardiac Oncology Network for a New Multidisciplinary Specialty.

artículo científico publicado en 2016

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

artículo científico publicado en 2016

Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines

artículo científico publicado en 2012

Catheter-related bloodstream infections, part I: pathogenesis, diagnosis, and management.

artículo científico publicado en 2002

Catheter-related bloodstream infections, part II: specific pathogens and prevention.

artículo científico publicado en 2003

Cetuximab for treating non-small cell lung cancer.

artículo científico publicado en 2018

Challenges and prospects of immunotherapy as cancer treatment.

artículo científico publicado en 2007

Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer.

artículo científico publicado en 2010

Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment

artículo científico publicado en 2004

Clinical considerations for the development of biosimilars in oncology

artículo científico publicado en 2015

Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer.

artículo científico publicado en 2018

Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial.

artículo científico publicado en 2019

Clinical relevance of HER2 overexpression/amplification in patients with small tumor size and node-negative breast cancer

artículo científico publicado en 2009

Clinical, Pathological, and Molecular Features of Breast Carcinoma Cutaneous Metastasis

artículo científico publicado en 2021

Coagulation disorders in patients with cancer: nontunneled central venous catheter placement with US guidance--a single-institution retrospective analysis

scientific article published on 30 June 2009

Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis

artículo científico publicado en 2019

Comparing granulocyte colony-stimulating factor filgrastim and pegfilgrastim to its biosimilars in terms of efficacy and safety: A meta-analysis of randomised clinical trials in breast cancer patients.

artículo científico publicado en 2017

Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life

artículo científico publicado en 2018

Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related disease pandemic

scientific article published on 06 April 2020

Correction: Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy.

artículo científico publicado en 2006

Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259].

artículo científico publicado en 2017

Crosstalk between bone niche and immune system: osteoimmunology signaling as a potential target for cancer treatment

artículo científico publicado en 2014

Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future? ⬇️

artículo científico publicado el 6 de septiembre de 2011

Cytotoxic effect of (1-methyl-1H-imidazol-2-yl)-methanamine and its derivatives in Pt(II) complexes on human carcinoma cell lines: a comparative study with cisplatin.

artículo científico publicado en 2013

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

artículo científico publicado en 2017

De-escalation attempts for adjuvant trastuzumab: longer beats shorter.

artículo científico publicado en 2015

Defining the immunogram of breast cancer: a focus on clinical trials

scientific article published on 01 April 2019

Delivering Cancer Care During the COVID-19 Pandemic: Recommendations and Lessons Learned From ASCO Global Webinars

scientific article published on 01 September 2020

Dendritic cell sarcoma: an analytic overview of the literature and presentation of original five cases.

artículo científico publicado en 2007

Dendritic cell-based vaccines: clinical applications in breast cancer.

artículo científico

Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer

artículo científico publicado en 2000

Detection of oncogene mutation from neoplastic colonic cells exfoliated in feces

artículo científico publicado en 1996

Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium.

artículo científico publicado en 2013

Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradient gel electrophoresis urinalysis

artículo científico publicado en 2001

Dinaciclib for the treatment of breast cancer.

artículo científico publicado en 2014

Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer

artículo científico publicado en 2013

Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer?

artículo científico publicado en 2014

Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer

artículo científico publicado en 2001

Drug-drug interactions in breast cancer patients treated with CDK4/6 inhibitors

artículo científico publicado en 2019

Drug-induced QTc interval prolongation: a proposal towards an efficient and safe anticancer drug development.

artículo científico publicado en 2007

Dual HER2 inhibition and pathological complete response in early breast cancer: increasing success of treatment by improving patient selection.

artículo científico publicado en 2017

ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer

scientific article published on 01 May 2020

EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants

artículo científico publicado en 2019

Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy

artículo científico publicado en 2015

Early-stage lung cancer--what do the experts recommend?

artículo científico publicado en 2014

Editorial: Optimizing treatment strategy in early breast cancer: less is more, or more is better?

scientific article published on 01 November 2019

Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients.

artículo científico publicado en 2001

Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden

artículo científico publicado en 2020

Emerging treatment landscape of non-muscle invasive bladder cancer

scientific article published in 2022

End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer--Alliance for Clinical Trials in Oncology--International Society Of Geriatric Oncology position article

artículo científico publicado en 2013

Entinostat for the treatment of breast cancer.

artículo científico

Evaluation of fat grafting safety in patients with intra epithelial neoplasia: a matched-cohort study ⬇️

artículo científico publicado el 7 de febrero de 2013

Evaluation of inter-observer variability according to RECIST 1.1 and its influence on response classification in CT measurement of liver metastases

artículo científico publicado en 2017

Evaluation of polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral cells by an immunohistochemical assay

scientific article published on 01 January 1999

Evidence for interleukin 17 involvement in severe immune-related neuroendocrine toxicity

artículo científico publicado en 2020

Expert perspectives on biosimilar monoclonal antibodies in breast cancer

artículo científico publicado en 2014

Extended Adjuvant Chemotherapy in Triple-Negative Breast Cancer.

artículo científico publicado en 2017

Extending indication of cyclin-dependent kinase 4/6 inhibitors in the adjuvant and neoadjuvant setting

artículo científico publicado en 2017

Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter

artículo científico publicado en 2004

Factor v leiden mutation in patients with breast cancer with a central venous catheter: risk of deep vein thrombosis

scientific article published on 01 January 2006

From precision medicine to cancer care through the immunome: highlights from the European Society of Medical Oncology Congress, Madrid, 26-30th September 2014.

artículo científico publicado en 2014

From the maximum tolerable to the minimum effective treatment: The Umberto Veronesi's life commitment to breast cancer care.

artículo científico publicado en 2016

Future perspectives in cancer immunotherapy

artículo científico publicado en 2016

Gemcitabine-induced progressive and sustained tumour response in a patient with multi-drug resistant uterine leiomyosarcoma.

artículo científico publicado en 2008

Gyneco-oncological genomics and emerging biomarkers for cancer treatment with immune-checkpoint inhibitors

scientific article published on 27 May 2018

HER2 Equivocal Status in Early Breast Cancer Is Not Associated with Higher Risk of Recurrence

artículo científico publicado en 2016

HER2 Signaling Pathway and Trastuzumab Cardiotoxicity ⬇️

artículo científico publicado el 1 de febrero de 2013

Harmonizing gene signatures to predict benefit from adjuvant chemotherapy in early breast cancer

artículo científico publicado en 2019

Health-related quality of life in patients with hormone refractory prostate cancer receiving gefitinib.

artículo científico publicado en 2009

Hepatic intra-arterial chemotherapy using a percutaneous catheter in pretreated patients with metastatic colorectal carcinoma.

artículo científico publicado en 2003

High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in luminal B HER2 negative and node-positive breast cancer.

artículo científico publicado en 2013

High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy.

artículo científico publicado en 2013

High-intensity focused ultrasound effect in breast cancer nodal metastasis

artículo científico publicado en 2010

Highlights from the 13th St Gallen International Breast Cancer Conference 2013. Access to innovation for patients with breast cancer: how to speed it up?

artículo científico publicado en 2013

Highlights from the 14(th) St Gallen International Breast Cancer Conference 2015 in Vienna: Dealing with classification, prognostication, and prediction refinement to personalize the treatment of patients with early breast cancer.

artículo científico publicado en 2015

Highlights from the 38th SABCS annual meeting, 8th - 12th December 2015, San Antonio, USA.

artículo científico publicado en 2016

Homologous recombination deficiency in triple negative breast cancer

scientific article published on 20 February 2019

How to Achieve Optimal Care in Early Breast Cancer with 'Less' or 'More' Treatment

artículo científico publicado en 2017

How to Guarantee the Best of Care to Patients with Cancer During the COVID-19 Epidemic: The Italian Experience

artículo científico publicado en 2020

How to treat lobular cancer in the adjuvant setting?

scientific article published on 19 August 2020

Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis.

artículo científico publicado en 2017

Ifosfamide in the elderly: clinical considerations for a better drug management.

artículo científico publicado en 2000

Imatinib administration in two patients with liver metastases from GIST and severe jaundice

artículo científico publicado en 2003

Immune approaches to the treatment of breast cancer, around the corner?

artículo científico publicado en 2014

Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander".

artículo científico publicado en 2014

Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.

artículo científico publicado en 2015

Immunity and autoimmunity in breast cancer.

artículo científico publicado en 2011

Immunity and autoimmunity: revising the concepts of response to breast cancer.

artículo científico

Immunizing against breast cancer: a new swing for an old sword

artículo científico publicado en 2009

Immunohistochemical analysis of 4-aminobiphenyl-DNA adducts in oral mucosal cells of smokers and nonsmokers

article

Immunohistochemical analysis of p53 protein in transplant recipients with Kaposi's sarcoma

article

Immunohistochemical detection of HER1/HER2 can be considered a predictive marker of gefitinib activity in non-small-cell lung cancer?

artículo científico publicado en 2005

Immunohistochemical quantitation of 4-aminobiphenyl-DNA adducts and p53 nuclear overexpression in T1 bladder cancer of smokers and nonsmokers

artículo científico publicado en 1996

Immunology and breast cancer: therapeutic cancer vaccines.

artículo científico publicado en 2007

Immunoscoring breast cancer: TILs remember what they target

artículo científico publicado en 2014

Immunosuppression and Multiple Primary Malignancies in Kidney-Transplanted Patients: A Single-Institute Study

artículo científico publicado en 2015

Immunotherapeutics for breast cancer

artículo científico publicado en 2013

Immunotherapy in breast cancer - towards a new understanding of both tumor and host

artículo científico publicado en 2012

Immunotherapy of Breast Cancer

artículo científico publicado en 2015

Impact of autoimmune diseases on outcome of patients with early breast cancer.

artículo científico publicado en 2016

Impact of limited pulmonary function on the management of resectable lung cancer

scientific article published on 01 July 2003

Impact of neoadjuvant chemotherapy and pathological complete response on eligibility for breast-conserving surgery in patients with early breast cancer: A meta-analysis

artículo científico publicado en 2018

Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study

artículo científico publicado en 2020

Implementing clinical practice guidelines: time to assess it

artículo científico publicado en 2020

In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients.

artículo científico publicado en 2006

Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): Is prophylaxis required?

artículo científico publicado en 2000

Inflammatory breast cancer and chest wall disease: The oncologist perspective

scientific article published on 22 May 2018

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013).

artículo científico publicado en 2015

International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010).

artículo científico

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial

artículo científico publicado en 2020

Intraobserver and interobserver variability in the calculation of apparent diffusion coefficient (ADC) from diffusion-weighted magnetic resonance imaging (DW-MRI) of breast tumours.

artículo científico publicado en 2011

Intrathecal chemotherapy in carcinomatous meningitis from breast cancer

artículo científico publicado en 2002

Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy

artículo científico publicado en 2014

Knowledge, attitudes and practice of physicians towards fertility and pregnancy-related issues in youngBRCA-mutated breast cancer patients

scientific article published on 10 January 2019

Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan

artículo científico publicado en 2014

Lessons from the first ecancer symposium on angiogenesis in gastric cancer.

artículo científico publicado en 2015

Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy

artículo científico publicado en 2006

Liquid biopsies for solid tumors: Understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapies.

artículo científico publicado en 2015

Liver toxicity in the era of immune checkpoint inhibitors: A practical approach

scientific article published on 03 October 2018

Locoregional recurrence in patients with HER2 positive breast cancer

artículo científico publicado en 2013

Locoregional recurrence risk after lipofilling in breast cancer patients

article

Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheter

artículo científico publicado en 2007

Lucitanib for the Treatment of HR+/HER2- Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study

scientific article published on 16 October 2019

Male breast cancer: a special therapeutic problem. Anything new? (Review).

artículo científico publicado en 2004

Management of Cardiac Toxicity Induced by Chemotherapy

scientific article published on 07 September 2020

Margetuximab for the treatment of HER2-Positive Metastatic Breast Cancer

artículo científico publicado en 2020

Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer

artículo científico publicado en 2017

Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist

artículo científico

Mediastinal lymphoadenopathy in a patient with breast cancer

artículo científico publicado en 2002

Metronomic administration of pegylated liposomal-doxorubicin in extensively pre-treated metastatic breast cancer patients: a mono-institutional case-series report

artículo científico publicado en 2009

Mismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy Efficacy.

artículo científico publicado en 2017

Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer.

artículo científico publicado en 2009

Modified-BEP Chemotherapy in Patients With Germ-Cell Tumors Treated at a Comprehensive Cancer Center

artículo científico publicado en 2020

Modulation of Epidermal Growth Factor Receptor Status by Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer Is Rare

artículo científico publicado en 2004

Molecular pathways: human leukocyte antigen G (HLA-G).

artículo científico

Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer.

artículo científico publicado en 2012

Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities

artículo científico publicado en 2013

Multidisciplinary approach in the treatment of patients with small cell bladder carcinoma ⬇️

artículo científico publicado el 8 de mayo de 2011

Neoadjuvant Model for Testing Emerging Targeted Therapies in Breast Cancer.

artículo científico publicado en 2015

New anti-HER2 agents for brain metastasis: histology-agnostic weapons?

artículo científico publicado en 2020

New approaches for improving outcomes in breast cancer in Europe

artículo científico

New drugs for breast cancer subtypes: Targeting driver pathways to overcome resistance ⬇️

artículo científico publicado el 18 de julio de 2011

Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer

scientific article published on 01 January 2019

Nipple-sparing mastectomy—is it worth the risk?

article published in 2011

No link between breast cancer and meningioma: results from a large monoinstitutional retrospective analysis

artículo científico publicado en 2013

Notch inhibitors and their role in the treatment of triple negative breast cancer: promises and failures

artículo científico publicado en 2017

Obesity increases the incidence of distant metastases in oestrogen receptor-negative human epidermal growth factor receptor 2-positive breast cancer patients.

artículo científico publicado en 2013

Optimal adjuvant chemotherapy in breast cancer: selection of agents

artículo científico

Optimization of the schedule of gemcitabine-cisplatin combination as induction regimen for patients with biopsy-proven stage IIIa N2 - stage IIIb non-small-cell lung cancer: a prospective phase-II study.

artículo científico publicado en 2004

Oral administration of vinorelbine can overcome intractable endovenous-vinorelbine-associated acute tumor pain.

artículo científico publicado en 2004

Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort report.

artículo científico publicado en 2012

Outcome and clinical-biological characteristics of patients with advanced breast cancer undergoing removal of ovarian/pelvic metastases.

artículo científico publicado en 2012

Outcome of Immediate Breast Reconstruction in Patients With Nonendocrine-Responsive Breast Cancer: A Monoinstitutional Case-Control Study.

artículo científico publicado en 2015

Over-using chemotherapy in the adjuvant setting

artículo científico publicado en 2016

P-170 Glycoprotein (MDR) and p53 Expression in Breast Cancer

scientific article published on 01 July 1998

Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial

artículo científico publicado en 2018

Palliative home care and cost savings: encouraging results from Italy

article

Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study

artículo científico publicado en 2014

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

artículo científico publicado en 2018

Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b-2 trial

scientific article published on 11 February 2019

Peptide vaccines in early breast cancer

artículo científico publicado en 2019

Perspectives on preoperative systemic treatment and breast conservative surgery: One step forward or two steps back?

artículo científico publicado en 2018

Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group

artículo científico publicado en 2018

Pharmacokinetic drug evaluation of ribociclib for the treatment of metastatic, hormone-positive breast cancer

artículo científico publicado en 2017

Pharmacological management of male breast cancer

artículo científico publicado en 2020

Phase 2 study of pembrolizumab (pembro) monotherapy for previously treated metastatic triple-negative breast cancer (mTNBC): KEYNOTE-086 cohort A

Phase I Study of Lysine-Specific Demethylase-1 Inhibitor CC-90011 in Patients With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma

artículo científico publicado en 2020

Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naïve patients with advanced non-small-cell lung cancer

artículo científico publicado en 2000

Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer

artículo científico publicado en 2016

Phase I study of twelve-day prolonged infusion of high-dose ifosfamide and doxorubicin as first-line chemotherapy in adult patients with advanced soft tissue sarcomas

artículo científico publicado en 2002

Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours

artículo científico publicado en 2020

Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer.

artículo científico publicado en 2009

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

artículo científico publicado en 2020

Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial

scientific article published on 14 January 2020

Postoperative hyperprolactinemia could predict longer disease-free and overall survival in node-negative breast cancer patients.

artículo científico publicado en 2002

Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies

artículo científico publicado en 2020

Pre-treatment blood parameters predict efficacy from immunotherapy agents in early phase clinical trials

artículo científico publicado en 2020

Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside

artículo científico publicado en 2019

Predictive and prognostic value of stromal tumour-infiltrating lymphocytes before and after neoadjuvant therapy in triple negative and HER2-positive breast cancer

scientific article published on 11 July 2019

Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study

artículo científico publicado en 2013

Preoperative and perioperative chemotherapy with 5-fluorouracil as continuous infusion in operable breast cancer expressing a high proliferation fraction: cytotoxic treatment during the surgical phase.

artículo científico publicado en 2003

Preoperative chemotherapy is essential for conservative surgery of Askin tumors.

artículo científico publicado en 2003

Prevention, Monitoring, and Management of Cardiac Dysfunction in Patients with Metastatic Breast Cancer

scientific article published on 07 May 2019

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date

artículo científico publicado en 2018

Prognostic and predictive value of tumor infiltrating lymphocytes in early breast cancer

artículo científico publicado en 2016

Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple negative breast cancer patients after neo-adjuvant chemotherapy

artículo científico publicado en 2019

Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer. An immunohistochemical analysis

article

Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer.

artículo científico publicado en 2012

Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer.

artículo científico publicado en 2012

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

artículo científico publicado en 2014

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

artículo científico publicado en 2015

Prognostic value of tumour-infiltrating lymphocytes in small HER2-positive breast cancer

artículo científico publicado en 2017

Progresses toward precision medicine in RET-altered solid tumors

artículo científico publicado en 2020

Promising antiproliferative platinum(II) complexes based on imidazole moiety: synthesis, evaluation in HCT-116 cancer cell line and interaction with Ctr-1 Met-rich domain.

artículo científico publicado en 2015

Prophylaxis for venous thromboembolism in cancer patients with a central vein catheter: new tones for an old song.

artículo científico publicado en 2005

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes

artículo científico publicado en 2014

QTc prolongation assessment in anticancer drug development: Clinical and methodological issues ⬇️

artículo científico publicado el 12 de enero de 2009

QTc prolongation induced by targeted biotherapies used in clinical practice and under investigation: a comprehensive review.

artículo científico

RNAi screens identify CHD4 as an essential gene in breast cancer growth

artículo científico publicado en 2016

Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer

artículo científico publicado en 2013

Re: Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients with 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial

artículo científico publicado en 2007

Re: Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non Small-Cell Lung Cancer

artículo científico publicado en 2007

Recent advances in triple negative breast cancer: the immunotherapy era

artículo científico publicado en 2019

Recognizing features that are dissimilar in male and female breast cancer: expression of p21Waf1 and p27Kip1 using an immunohistochemical assay

artículo científico publicado en 2002

Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration

artículo científico publicado en 2015

Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al.

artículo científico publicado en 2017

Reply to L.K. Mell et al

Reply to the article “Metronomic therapy with cyclophosphamide induces rat lymphoma and sarcoma regression, and is devoid of toxicity” by V. R. Rozados et al. (Ann Oncol 2004; 15: 1543–1550): … and in humans?

scientific article published on 16 February 2005

Repurposing anticancer drugs for the management of COVID-19

artículo científico publicado en 2020

Response rate as a potential surrogate for survival and efficacy in patients treated with novel immune checkpoint inhibitors: A meta-regression of randomised prospective studies

artículo científico publicado en 2017

Response to Letters Regarding Article, “Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy”

artículo científico publicado en 2016

Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors

article

Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy

artículo científico publicado en 2005

Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study

artículo científico publicado en 2016

Risk factors associated with recurrence after nipple-sparing mastectomy for invasive and intraepithelial neoplasia

article

Risk of Locoregional Recurrence in Patients With False-Negative Frozen Section or Close Margins of Retroareolar Specimen in Nipple-Sparing Mastectomy

artículo científico publicado en 2012

Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.

artículo científico publicado en 2015

Robotic nipple-sparing mastectomy for the treatment of breast cancer: Feasibility and safety study

artículo científico publicado en 2016

SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab

artículo científico publicado en 2017

Safety and Tolerability of Phosphatidylinositol-3-Kinase (PI3K) Inhibitors in Oncology

scientific article published on 01 February 2019

Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study.

artículo científico publicado en 2017

Safety of Novel Targeted Therapies in Oncology

scientific article published on 01 February 2019

Safety, Tolerability, and Management of Toxic Effects of Phosphatidylinositol 3-Kinase Inhibitor Treatment in Patients With Cancer: A Review

artículo científico publicado en 2019

Seroconversion in patients with cancer and oncology healthcare workers infected by SARS-CoV-2

artículo científico publicado en 2020

Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group

artículo científico

Strategies to modulate the immune system in breast cancer: checkpoint inhibitors and beyond

artículo científico publicado en 2016

Successes and limitations of targeted cancer therapy in breast cancer

artículo científico

Surgery of the primary tumor in de novo metastatic breast cancer: To do or not to do?

artículo científico

Switching between intravenous and subcutaneous trastuzumab: Safety results from the PrefHer trial.

artículo científico publicado en 2017

Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers

scientific article published on 11 May 2020

Systemic Effects of Surgery: Quantitative Analysis of Circulating Basic Fibroblast Growth Factor (bFGF), Vascular Endothelial Growth Factor (VEGF) and Transforming Growth Factor Beta (TGF-β) in Patients with Breast Cancer Who Underwent Limited or Ex

article

Systemic therapies for non-metastatic prostate cancer: review of the literature.

artículo científico publicado en 2009

Tailoring adjuvant treatments for the individual patient with luminal breast cancer.

artículo científico publicado en 2013

Talking to patients about biosimilars

scientific article published on 01 June 2018

Target-Treatment and Patients' Selection: Can We Still Neglect the Timing of Tissue Collection?

artículo científico publicado en 2005

Targeting fibroblast growth factor receptor pathway in breast cancer

artículo científico

Targeting the microenvironment in solid tumors

artículo científico publicado en 2018

Targeting the subtypes of breast cancer: rethinking investigational drugs

artículo científico

The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients

artículo científico publicado en 2018

The Emerging Role of "Liquid Biopsies," Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations.

artículo científico publicado en 2017

The Legacy of Professor Aron Goldhirsch

artículo científico publicado en 2020

The PROMISe to increase precision in adjuvant therapy for early breast cancer: To "Type" or to "Print"?

artículo científico publicado en 2018

The Triple-Negative Subtype: New Ideas for the Poorest Prognosis Breast Cancer

artículo científico publicado en 2011

The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region

scientific article published on 29 April 2020

The influential and inspirational Gianni Bonadonna's life commitment to evidence-based cancer medicine.

artículo científico publicado en 2015

The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy

article

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.

artículo científico publicado en 2017

The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trials.

artículo científico publicado en 2017

The role of histone deacetylase inhibitors in metastatic breast cancer

artículo científico publicado en 2018

The tumour-targeting human L19-IL2 immunocytokine: preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma

artículo científico publicado en 2010

The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO.

artículo científico publicado en 2017

To switch or not to switch: implications of sequencing adjuvant endocrine therapy in patients with breast cancer

artículo científico publicado en 2007

Towards Better Pharmaceutical Provision in Europe-Who Decides the Future?

artículo científico publicado en 2022

Trabectedin for women with ovarian carcinoma after treatment with platinum and taxanes fails.

artículo científico publicado en 2005

Treatment in real-life patients with HER2-positive metastatic breast cancer: What we learn from the KAMILLA trial?

artículo científico publicado en 2019

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

artículo científico publicado en 2019

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.

artículo científico publicado en 2016

Tumor-infiltrating lymphocytes in Breast Cancer and implications for clinical practice

artículo científico publicado en 2017

Tumor-stroma crosstalk: targeting stroma in breast cancer.

artículo científico publicado en 2014

Tumour dormancy and clinical implications in breast cancer.

artículo científico publicado en 2013

Tumour infiltrating lymphocytes and correlation with response to intensified platinum-based chemotherapy in BRCA-like tumours

scientific article published on 20 January 2020

Ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation in pancreatic metastasis from renal cell carcinoma

artículo científico publicado en 2012

Understanding cognitive processes behind acceptance or refusal of phase I trials

artículo científico publicado en 2016

Vaccine immunotherapy in breast cancer treatment: promising, but still early.

artículo científico publicado en 2007

Venous thromboembolism and cancer: new issues for an old topic.

artículo científico publicado en 2003

Vinorelbine-based chemotherapy in hormone-refractory prostate cancer

artículo científico publicado en 2006

“Burned out” phenomenon of the testis in retroperitoneal seminoma

artículo científico publicado en 2006

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda